Free Trial

Daktronics (DAKT) Financials

Daktronics logo
$15.60 +0.29 (+1.89%)
Closing price 04:00 PM Eastern
Extended Trading
$15.61 +0.01 (+0.06%)
As of 06:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Daktronics

Annual Income Statements for Daktronics

This table shows Daktronics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 4/27/2024 4/29/2023 4/30/2022
Net Income / (Loss) Attributable to Common Shareholders
35 6.80 0.59
Consolidated Net Income / (Loss)
35 6.80 0.59
Net Income / (Loss) Continuing Operations
35 6.80 0.59
Total Pre-Tax Income
54 13 1.11
Total Operating Income
87 21 4.05
Total Gross Profit
222 151 117
Total Revenue
818 754 611
Operating Revenue
818 754 611
Total Cost of Revenue
596 603 494
Operating Cost of Revenue
596 603 494
Total Operating Expenses
135 130 113
Selling, General & Admin Expense
100 95 84
Research & Development Expense
36 30 29
Impairment Charge
0.00 4.58 0.00
Total Other Income / (Expense), net
-33 -8.13 -2.94
Interest & Investment Income
-3.42 -0.92 0.17
Other Income / (Expense), net
-30 -7.21 -3.11
Income Tax Expense
19 6.46 0.52
Basic Earnings per Share
$0.75 $0.15 $0.01
Weighted Average Basic Shares Outstanding
45.90M 45.40M 45.19M
Diluted Earnings per Share
$0.74 $0.15 $0.01
Weighted Average Diluted Shares Outstanding
46.54M 45.52M 45.33M
Weighted Average Basic & Diluted Shares Outstanding
46.30M 45.70M 45.03M

Quarterly Income Statements for Daktronics

This table shows Daktronics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 1/25/2025 10/26/2024 7/27/2024 4/27/2024 1/27/2024 10/28/2023 7/29/2023 4/29/2023 1/28/2023 10/29/2022 7/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-17 21 -4.95 2.52 11 2.17 19 17 8.29 -13 -5.33
Consolidated Net Income / (Loss)
-17 21 -4.95 2.52 11 2.17 19 21 3.71 -13 -5.33
Net Income / (Loss) Continuing Operations
-17 21 -4.95 2.52 11 2.17 19 17 8.29 -13 -5.33
Total Pre-Tax Income
-18 25 0.22 7.17 13 6.16 28 13 5.34 1.06 -6.33
Total Operating Income
-3.63 16 23 19 8.04 19 40 18 7.12 1.53 -5.52
Total Gross Profit
37 56 60 55 42 54 71 52 42 32 26
Total Revenue
150 208 226 216 170 199 233 210 185 187 172
Operating Revenue
150 208 226 216 170 199 233 210 185 187 172
Total Cost of Revenue
113 152 166 161 129 145 161 158 143 156 146
Operating Cost of Revenue
113 152 166 161 129 145 161 158 143 156 146
Total Operating Expenses
40 40 37 36 34 35 31 38 30 30 31
Selling, General & Admin Expense
31 30 27 27 25 26 23 26 23 23 24
Research & Development Expense
9.44 9.84 9.62 9.28 8.84 9.22 8.40 8.33 7.25 6.97 7.44
Total Other Income / (Expense), net
-14 9.41 -22 -12 4.60 -13 -12 -5.14 -1.78 -0.47 -0.75
Interest & Investment Income
0.51 0.27 -0.07 -0.47 -0.75 -1.33 -0.88 - -0.40 -0.26 -
Other Income / (Expense), net
-15 9.14 -22 -12 5.34 -12 -11 -4.88 -1.38 -0.21 -0.75
Income Tax Expense
-0.66 3.78 5.17 4.65 1.89 3.99 8.90 -8.21 1.63 14 -1.00
Basic Earnings per Share
($0.36) $0.46 ($0.11) $0.05 $0.23 $0.05 $0.42 $0.48 $0.08 ($0.29) ($0.12)
Weighted Average Basic Shares Outstanding
47.76M 46.80M 46.31M 45.90M 46.17M 46.03M 45.65M 45.40M 45.39M 45.32M 45.10M
Diluted Earnings per Share
($0.36) $0.22 ($0.11) $0.18 $0.09 $0.05 $0.42 $0.48 $0.08 ($0.29) ($0.12)
Weighted Average Diluted Shares Outstanding
47.76M 51.72M 46.31M 46.54M 50.84M 46.71M 46.20M 45.52M 45.45M 45.32M 45.10M
Weighted Average Basic & Diluted Shares Outstanding
49.89M 46.99M 46.65M 46.30M 46.19M 46.18M 45.72M 45.70M 45.47M 45.47M 45.03M

Annual Cash Flow Statements for Daktronics

This table details how cash moves in and out of Daktronics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 4/27/2024 4/29/2023 4/30/2022
Net Change in Cash & Equivalents
57 6.68 -62
Net Cash From Operating Activities
63 15 -27
Net Cash From Continuing Operating Activities
63 15 -27
Net Income / (Loss) Continuing Operations
35 6.80 0.59
Consolidated Net Income / (Loss)
35 6.80 0.59
Depreciation Expense
19 17 15
Non-Cash Adjustments To Reconcile Net Income
33 15 3.91
Changes in Operating Assets and Liabilities, net
-23 -23 -47
Net Cash From Investing Activities
-21 -25 -31
Net Cash From Continuing Investing Activities
-21 -25 -31
Purchase of Property, Plant & Equipment
-17 -25 -20
Acquisitions
-5.05 -4.32 -7.85
Purchase of Investments
0.00 0.00 -4.05
Sale of Property, Plant & Equipment
0.17 0.82 0.89
Sale and/or Maturity of Investments
0.55 3.49 0.00
Net Cash From Financing Activities
15 18 -3.58
Net Cash From Continuing Financing Activities
15 18 -3.58
Repayment of Debt
-27 -362 -47
Repurchase of Common Equity
0.00 0.00 -3.18
Issuance of Debt
41 380 47
Other Financing Activities, net
1.00 -0.12 -0.19
Effect of Exchange Rate Changes
-0.07 -0.52 -0.40

Quarterly Cash Flow Statements for Daktronics

This table details how cash moves in and out of Daktronics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 1/25/2025 10/26/2024 7/27/2024 4/27/2024 1/27/2024 10/28/2023 7/29/2023 4/29/2023 1/28/2023 10/29/2022 7/30/2022
Net Change in Cash & Equivalents
-2.18 37 16 4.49 4.21 19 30 14 3.59 -1.89 -8.98
Net Cash From Operating Activities
12 43 19 9.45 9.48 25 19 25 12 0.88 -23
Net Cash From Continuing Operating Activities
12 43 19 9.45 9.48 25 19 25 12 0.88 -23
Net Income / (Loss) Continuing Operations
-17 21 -4.95 2.52 11 2.17 19 21 3.71 -13 -5.33
Consolidated Net Income / (Loss)
-17 21 -4.95 2.52 11 2.17 19 21 3.71 -13 -5.33
Depreciation Expense
4.91 4.90 4.89 4.92 4.88 4.83 4.67 4.45 4.32 4.20 4.03
Non-Cash Adjustments To Reconcile Net Income
15 -9.31 23 12 -4.11 13 12 5.98 5.90 1.63 1.22
Changes in Operating Assets and Liabilities, net
9.25 26 -3.75 -9.82 -2.03 5.51 -17 -7.32 -1.48 8.03 -23
Net Cash From Investing Activities
-5.40 -6.41 -5.97 -4.25 -4.98 -6.37 -5.71 -4.44 -5.76 -4.82 -10
Net Cash From Continuing Investing Activities
-5.40 -6.41 -5.97 -4.25 -4.98 -6.37 -5.71 -4.44 -5.76 -4.82 -10
Purchase of Property, Plant & Equipment
-4.20 -5.39 -5.08 -3.35 -4.40 -4.68 -4.55 -3.58 -5.57 -5.58 -11
Acquisitions
-1.29 -1.11 -0.93 -0.97 -1.19 -1.71 -1.19 -1.08 -0.36 -1.80 -1.08
Sale of Property, Plant & Equipment
0.09 0.08 0.05 0.07 0.06 0.03 0.03 0.21 0.18 0.07 0.37
Net Cash From Financing Activities
-8.63 -0.03 2.06 -0.57 -0.23 -0.44 16 -5.93 -2.78 2.15 24
Net Cash From Continuing Financing Activities
-8.63 -0.03 2.06 -0.57 -0.23 -0.44 16 -5.93 -2.78 2.15 24
Repayment of Debt
-0.48 -0.48 -1.09 -1.41 -0.86 -1.09 -24 -103 -95 -96 -68
Other Financing Activities, net
0.87 0.45 3.15 0.16 0.14 0.66 0.05 0.02 - -0.14 0.00
Effect of Exchange Rate Changes
-0.18 0.27 -0.06 -0.15 -0.06 0.38 -0.24 -0.18 -0.33 -0.09 0.08
Cash Interest Paid
0.89 0.88 0.89 - 0.93 0.93 0.10 - 0.42 0.26 0.08
Cash Income Taxes Paid
3.71 3.83 9.08 - 6.31 6.10 5.77 - 1.99 1.79 0.69

Annual Balance Sheets for Daktronics

This table presents Daktronics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 4/27/2024 4/29/2023 4/30/2022
Total Assets
528 468 441
Total Current Assets
402 343 318
Cash & Equivalents
81 24 17
Restricted Cash
0.38 0.71 0.87
Note & Lease Receivable
0.30 1.22 2.80
Accounts Receivable
117 110 101
Inventories, net
138 149 134
Prepaid Expenses
8.53 9.68 15
Current Deferred & Refundable Income Taxes
0.45 0.33 0.60
Other Current Assets
56 47 42
Plant, Property, & Equipment, net
72 72 67
Total Noncurrent Assets
54 53 57
Long-Term Investments
21 28 32
Noncurrent Note & Lease Receivables
0.56 0.26 1.49
Goodwill
3.23 3.24 7.93
Intangible Assets
0.84 1.14 1.47
Noncurrent Deferred & Refundable Income Taxes
26 17 13
Other Noncurrent Operating Assets
2.53 3.87 0.00
Total Liabilities & Shareholders' Equity
528 468 441
Total Liabilities
289 267 249
Total Current Liabilities
192 210 214
Short-Term Debt
1.50 0.00 -
Accounts Payable
61 68 76
Accrued Expenses
60 48 47
Current Deferred & Payable Income Tax Liabilities
4.95 2.86 0.41
Other Current Liabilities
66 92 90
Total Noncurrent Liabilities
97 57 36
Long-Term Debt
53 18 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
0.14 0.20 0.29
Other Noncurrent Operating Liabilities
43 39 35
Total Equity & Noncontrolling Interests
239 201 192
Total Preferred & Common Equity
239 201 192
Preferred Stock
0.00 0.00 0.00
Total Common Equity
239 201 192
Common Stock
118 113 110
Retained Earnings
138 103 97
Treasury Stock
-10 -10 -10
Accumulated Other Comprehensive Income / (Loss)
-6.53 -5.53 -4.93

Quarterly Balance Sheets for Daktronics

This table presents Daktronics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023
Period end date 1/25/2025 10/26/2024 7/27/2024 1/27/2024 10/28/2023 7/29/2023 1/28/2023 10/29/2022 7/30/2022
Total Assets
524 552 554 499 511 508 454 464 473
Total Current Assets
394 423 427 376 386 387 342 346 343
Cash & Equivalents
132 134 97 77 65 46 10 6.43 8.28
Restricted Cash
0.00 0.00 0.38 0.43 8.25 8.58 0.71 0.71 0.75
Note & Lease Receivable
1.78 1.27 0.44 0.27 0.77 0.97 1.72 1.74 1.62
Accounts Receivable
96 111 132 101 115 126 116 115 113
Inventories, net
113 122 135 140 142 145 165 168 157
Prepaid Expenses
7.34 9.18 8.58 7.85 10 9.85 8.77 11 12
Current Deferred & Refundable Income Taxes
5.04 0.14 0.11 1.50 0.00 0.01 3.26 3.22 2.32
Other Current Assets
40 45 54 48 45 51 36 39 45
Plant, Property, & Equipment, net
74 74 74 72 73 72 74 74 72
Total Noncurrent Assets
56 55 53 51 52 49 38 44 58
Long-Term Investments
24 21 21 27 28 28 33 34 34
Noncurrent Note & Lease Receivables
1.78 2.54 0.12 0.10 0.15 0.15 0.45 0.73 1.12
Goodwill
3.09 3.19 3.20 3.26 3.20 3.33 3.29 7.64 7.86
Intangible Assets
0.60 0.70 0.77 0.92 0.97 1.09 1.22 1.25 1.39
Noncurrent Deferred & Refundable Income Taxes
25 26 26 17 17 17 0.00 0.00 13
Other Noncurrent Operating Assets
1.60 1.91 2.22 2.84 3.15 0.00 - - -
Total Liabilities & Shareholders' Equity
524 552 554 499 511 508 454 464 473
Total Liabilities
252 291 316 263 288 287 274 291 287
Total Current Liabilities
162 180 197 170 190 204 212 227 225
Short-Term Debt
1.50 1.50 1.50 1.50 1.50 1.50 - - -
Accounts Payable
45 57 67 49 54 62 71 87 82
Accrued Expenses
50 58 56 50 53 46 44 49 45
Current Deferred & Payable Income Tax Liabilities
0.21 0.53 0.54 0.63 3.35 5.51 0.38 0.46 0.26
Other Current Liabilities
66 62 72 69 78 89 98 90 96
Total Noncurrent Liabilities
89 111 119 93 98 83 62 64 62
Long-Term Debt
41 64 74 48 55 41 24 26 24
Noncurrent Deferred & Payable Income Tax Liabilities
0.14 0.14 0.14 0.20 0.19 0.20 0.00 0.00 0.29
Other Noncurrent Operating Liabilities
48 47 44 44 43 41 38 38 38
Total Equity & Noncontrolling Interests
272 261 238 236 223 221 179 173 187
Total Preferred & Common Equity
272 261 238 236 223 221 179 173 187
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
272 261 238 236 223 221 179 173 187
Common Stock
162 123 122 117 116 115 113 112 111
Retained Earnings
137 154 133 136 125 123 82 78 91
Treasury Stock
-19 -10 -10 -10 -10 -10 -10 -10 -10
Accumulated Other Comprehensive Income / (Loss)
-7.39 -6.06 -6.40 -5.91 -6.96 -5.77 -5.11 -7.09 -5.57

Annual Metrics And Ratios for Daktronics

This table displays calculated financial ratios and metrics derived from Daktronics' official financial filings.

Metric 2024 2023 2022
Period end date 4/27/2024 4/29/2023 4/30/2022
Growth Metrics
- - -
Revenue Growth
8.47% 23.44% 26.75%
EBITDA Growth
146.26% 90.86% -47.66%
EBIT Growth
305.37% 1,413.02% -93.37%
NOPAT Growth
408.47% 407.64% -83.74%
Net Income Growth
408.98% 1,048.99% -94.58%
EPS Growth
393.33% 1,400.00% -95.83%
Operating Cash Flow Growth
320.93% 155.57% -140.83%
Free Cash Flow Firm Growth
277.36% 64.94% -247.69%
Invested Capital Growth
15.19% 20.60% 60.02%
Revenue Q/Q Growth
0.74% 6.75% 8.01%
EBITDA Q/Q Growth
-6.44% 90.43% -9.55%
EBIT Q/Q Growth
-9.10% 56,808.00% -58.94%
NOPAT Q/Q Growth
-27.11% 458.70% -52.09%
Net Income Q/Q Growth
-35.29% 143.29% -69.89%
EPS Q/Q Growth
-28.85% 142.86% -50.00%
Operating Cash Flow Q/Q Growth
-19.23% 235.87% -261.77%
Free Cash Flow Firm Q/Q Growth
-42.68% 33.50% -22.51%
Invested Capital Q/Q Growth
4.90% 4.30% 5.00%
Profitability Metrics
- - -
Gross Margin
27.19% 20.07% 19.10%
EBITDA Margin
9.38% 4.13% 2.67%
Operating Margin
10.65% 2.84% 0.66%
EBIT Margin
7.02% 1.88% 0.15%
Profit (Net Income) Margin
4.23% 0.90% 0.10%
Tax Burden Percent
64.05% 51.31% 53.43%
Interest Burden Percent
94.05% 93.51% 118.25%
Effective Tax Rate
35.95% 48.69% 46.57%
Return on Invested Capital (ROIC)
31.34% 7.25% 1.94%
ROIC Less NNEP Spread (ROIC-NNEP)
82.02% 16.55% 3.88%
Return on Net Nonoperating Assets (RNNOA)
-15.59% -3.78% -1.63%
Return on Equity (ROE)
15.75% 3.47% 0.31%
Cash Return on Invested Capital (CROIC)
17.22% -11.42% -44.23%
Operating Return on Assets (OROA)
11.54% 3.12% 0.23%
Return on Assets (ROA)
6.95% 1.50% 0.15%
Return on Common Equity (ROCE)
15.75% 3.47% 0.31%
Return on Equity Simple (ROE_SIMPLE)
14.50% 3.39% 0.31%
Net Operating Profit after Tax (NOPAT)
56 11 2.16
NOPAT Margin
6.82% 1.46% 0.35%
Net Nonoperating Expense Percent (NNEP)
-50.68% -9.30% -1.94%
Cost of Revenue to Revenue
72.81% 79.93% 80.90%
SG&A Expenses to Revenue
12.17% 12.65% 13.69%
R&D to Revenue
4.37% 3.98% 4.75%
Operating Expenses to Revenue
16.54% 17.23% 18.44%
Earnings before Interest and Taxes (EBIT)
57 14 0.94
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
77 31 16
Valuation Ratios
- - -
Price to Book Value (P/BV)
1.80 1.09 0.80
Price to Tangible Book Value (P/TBV)
1.83 1.11 0.84
Price to Revenue (P/Rev)
0.52 0.29 0.25
Price to Earnings (P/E)
12.39 32.15 257.28
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
8.07% 3.11% 0.39%
Enterprise Value to Invested Capital (EV/IC)
2.00 1.11 0.71
Enterprise Value to Revenue (EV/Rev)
0.47 0.24 0.16
Enterprise Value to EBITDA (EV/EBITDA)
4.96 5.88 6.00
Enterprise Value to EBIT (EV/EBIT)
6.63 12.93 104.55
Enterprise Value to NOPAT (EV/NOPAT)
6.83 16.70 45.32
Enterprise Value to Operating Cash Flow (EV/OCF)
6.02 12.20 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
12.42 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.23 0.09 0.00
Long-Term Debt to Equity
0.22 0.09 0.00
Financial Leverage
-0.19 -0.23 -0.42
Leverage Ratio
2.27 2.32 2.12
Compound Leverage Factor
2.13 2.17 2.51
Debt to Total Capital
18.63% 8.12% 0.00%
Short-Term Debt to Total Capital
0.51% 0.00% 0.00%
Long-Term Debt to Total Capital
18.12% 8.12% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
81.37% 91.88% 100.00%
Debt to EBITDA
0.71 0.57 0.00
Net Debt to EBITDA
-0.63 -1.14 0.00
Long-Term Debt to EBITDA
0.69 0.57 0.00
Debt to NOPAT
0.98 1.62 0.00
Net Debt to NOPAT
-0.86 -3.23 0.00
Long-Term Debt to NOPAT
0.95 1.62 0.00
Altman Z-Score
3.64 2.85 2.35
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
2.09 1.63 1.49
Quick Ratio
1.03 0.65 0.59
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
31 -17 -49
Operating Cash Flow to CapEx
376.30% 61.17% -138.71%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
1.64 1.66 1.50
Accounts Receivable Turnover
7.20 7.15 7.23
Inventory Turnover
4.14 4.25 4.74
Fixed Asset Turnover
11.37 10.86 9.74
Accounts Payable Turnover
9.29 8.38 8.48
Days Sales Outstanding (DSO)
50.68 51.08 50.45
Days Inventory Outstanding (DIO)
88.07 85.93 77.08
Days Payable Outstanding (DPO)
39.30 43.54 43.04
Cash Conversion Cycle (CCC)
99.45 93.46 84.49
Capital & Investment Metrics
- - -
Invested Capital
191 165 137
Invested Capital Turnover
4.59 4.98 5.48
Increase / (Decrease) in Invested Capital
25 28 51
Enterprise Value (EV)
381 183 98
Market Capitalization
429 219 152
Book Value per Share
$5.17 $4.42 $4.21
Tangible Book Value per Share
$5.08 $4.32 $4.01
Total Capital
293 219 192
Total Debt
55 18 0.00
Total Long-Term Debt
53 18 0.00
Net Debt
-48 -35 -54
Capital Expenditures (CapEx)
17 25 19
Debt-free, Cash-free Net Working Capital (DFCFNWC)
129 107 82
Debt-free Net Working Capital (DFNWC)
211 132 104
Net Working Capital (NWC)
210 132 104
Net Nonoperating Expense (NNE)
21 4.17 1.57
Net Nonoperating Obligations (NNO)
-48 -35 -54
Total Depreciation and Amortization (D&A)
19 17 15
Debt-free, Cash-free Net Working Capital to Revenue
15.83% 14.22% 13.40%
Debt-free Net Working Capital to Revenue
25.81% 17.57% 17.00%
Net Working Capital to Revenue
25.63% 17.57% 17.00%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.75 $0.15 $0.01
Adjusted Weighted Average Basic Shares Outstanding
45.90M 45.40M 45.19M
Adjusted Diluted Earnings per Share
$0.74 $0.15 $0.01
Adjusted Weighted Average Diluted Shares Outstanding
46.54M 45.52M 45.33M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
46.30M 45.70M 45.03M
Normalized Net Operating Profit after Tax (NOPAT)
56 13 2.16
Normalized NOPAT Margin
6.82% 1.77% 0.35%
Pre Tax Income Margin
6.61% 1.76% 0.18%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 537.84%

Quarterly Metrics And Ratios for Daktronics

This table displays calculated financial ratios and metrics derived from Daktronics' official financial filings.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 1/25/2025 10/26/2024 7/27/2024 4/27/2024 1/27/2024 10/28/2023 7/29/2023 4/29/2023 1/28/2023 10/29/2022 7/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-12.21% 4.50% -2.77% 2.87% -7.93% 6.36% 35.26% 29.38% 32.54% 13.96% 18.79%
EBITDA Growth
-173.48% 142.21% -84.59% -29.62% 81.50% 123.05% 1,601.38% 487.71% 469.98% -23.04% -125.34%
EBIT Growth
-236.99% 232.89% -99.00% -42.98% 133.11% 467.75% 562.45% 1,742.58% 188.65% -61.61% -230.76%
NOPAT Growth
-137.16% 96.14% -1,958.65% -76.97% 38.08% 136.39% 811.22% 13,370.83% 224.48% -708.70% -191.30%
Net Income Growth
-259.71% 888.73% -125.77% -88.23% 189.31% 116.67% 460.42% 2,015.76% 185.36% -646.93% -244.53%
EPS Growth
-500.00% 340.00% -126.19% -62.50% 12.50% 117.24% 450.00% 2,500.00% 180.00% -680.00% -250.00%
Operating Cash Flow Growth
26.81% 72.93% 1.20% -61.44% -23.88% 2,757.58% 184.37% 1,660.22% 173.54% 111.67% -2,138.96%
Free Cash Flow Firm Growth
226.33% 242.55% -4,925.47% -1,434.08% 29.50% 77.16% 114.77% 102.66% 52.78% -244.91% -446.16%
Invested Capital Growth
-12.68% -4.31% 8.32% 15.19% 14.53% 13.78% 10.07% 20.60% 21.40% 41.46% 73.83%
Revenue Q/Q Growth
-28.24% -7.85% 4.73% 26.76% -14.58% -14.26% 10.80% 13.45% -1.31% 9.03% 5.99%
EBITDA Q/Q Growth
-144.99% 475.06% -58.71% -31.22% 48.29% -63.42% 88.63% 77.38% 82.24% 346.23% -173.84%
EBIT Q/Q Growth
-173.56% 8,460.14% -96.19% -42.94% 78.75% -74.18% 116.46% 133.30% 335.36% 121.03% -668.83%
NOPAT Q/Q Growth
-118.95% 102.62% -7,582.37% -0.13% 0.00% -75.13% -7.28% 498.75% 126.35% -386.13% -1,630.09%
Net Income Q/Q Growth
-180.15% 532.79% -296.43% -76.56% 396.17% -88.72% -10.29% 476.33% 128.60% -143.79% -376.81%
EPS Q/Q Growth
-263.64% 300.00% -161.11% 100.00% 80.00% -88.10% -12.50% 500.00% 127.59% -141.67% -500.00%
Operating Cash Flow Q/Q Growth
-72.27% 122.47% 106.10% -0.27% -62.18% 30.19% -21.46% 96.86% 1,319.73% 103.84% -1,352.26%
Free Cash Flow Firm Q/Q Growth
-2.85% 104.01% -2,770.92% -12.89% -9.63% -235.81% 693.71% 105.97% 64.48% 12.21% -42.75%
Invested Capital Q/Q Growth
-7.15% -12.94% 2.98% 4.90% 1.76% -1.46% 9.51% 4.30% 1.09% -4.67% 19.98%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
24.60% 26.81% 26.40% 25.65% 24.50% 27.19% 30.60% 24.85% 22.55% 16.91% 15.00%
EBITDA Margin
-8.97% 14.31% 2.29% 5.82% 10.72% 6.17% 14.47% 8.50% 5.44% 2.94% -1.30%
Operating Margin
-2.43% 7.57% 10.05% 9.00% 4.72% 9.75% 17.29% 8.70% 3.85% 0.81% -3.21%
EBIT Margin
-12.26% 11.96% 0.13% 3.54% 7.85% 3.75% 12.46% 6.38% 3.10% 0.70% -3.64%
Profit (Net Income) Margin
-11.48% 10.28% -2.19% 1.17% 6.31% 1.09% 8.26% 10.20% 2.01% -6.93% -3.10%
Tax Burden Percent
96.30% 85.00% -2,248.18% 35.13% 85.04% 35.16% 68.32% 162.26% 69.53% -1,230.71% 84.19%
Interest Burden Percent
97.23% 101.10% 75.60% 93.89% 94.43% 82.28% 96.96% 98.51% 93.06% 80.05% 100.96%
Effective Tax Rate
0.00% 15.00% 2,348.18% 64.87% 14.96% 64.84% 31.68% -62.26% 30.47% 1,330.71% 0.00%
Return on Invested Capital (ROIC)
-7.98% 30.22% -971.32% 14.53% 19.15% 16.89% 55.68% 70.37% 13.07% -49.46% -11.06%
ROIC Less NNEP Spread (ROIC-NNEP)
9.40% 18.34% -2,208.52% 24.83% 8.76% 32.40% 82.43% 88.72% 16.02% -60.45% -8.73%
Return on Net Nonoperating Assets (RNNOA)
-3.11% -5.10% 393.16% -4.72% -1.59% -4.93% -12.51% -20.29% -3.60% 17.08% 2.85%
Return on Equity (ROE)
-11.09% 25.12% -578.16% 9.81% 17.56% 11.96% 43.16% 50.08% 9.47% -32.38% -8.21%
Cash Return on Invested Capital (CROIC)
17.47% 29.22% 6.78% 17.22% 31.43% 31.74% 15.91% -11.42% -17.97% -39.57% -57.77%
Operating Return on Assets (OROA)
-19.16% 18.46% 0.20% 5.81% 13.39% 6.37% 20.69% 10.59% 5.05% 1.05% -5.35%
Return on Assets (ROA)
-17.94% 15.87% -3.34% 1.92% 10.75% 1.84% 13.71% 16.92% 3.27% -10.39% -4.55%
Return on Common Equity (ROCE)
-11.09% 25.12% -578.16% 9.81% 17.56% 11.96% 43.16% 50.08% 9.47% -32.38% -8.21%
Return on Equity Simple (ROE_SIMPLE)
0.67% 11.39% 4.40% 0.00% 22.65% 20.82% 14.17% 0.00% -8.76% -13.78% -4.51%
Net Operating Profit after Tax (NOPAT)
-2.54 13 -511 6.83 6.83 6.83 27 30 4.95 -19 -3.86
NOPAT Margin
-1.70% 6.43% -225.88% 3.16% 4.01% 3.43% 11.82% 14.12% 2.68% -10.02% -2.25%
Net Nonoperating Expense Percent (NNEP)
-17.38% 11.88% 1,237.21% -10.31% 10.39% -15.50% -26.75% -18.35% -2.95% 10.99% -2.33%
Return On Investment Capital (ROIC_SIMPLE)
-0.81% - - - 2.39% - - - - - -
Cost of Revenue to Revenue
75.40% 73.19% 73.60% 74.35% 75.50% 72.81% 69.40% 75.15% 77.45% 83.09% 85.00%
SG&A Expenses to Revenue
20.71% 14.52% 12.10% 12.35% 14.59% 12.81% 9.69% 12.17% 12.31% 12.38% 13.89%
R&D to Revenue
6.31% 4.72% 4.26% 4.30% 5.19% 4.63% 3.61% 3.97% 3.92% 3.72% 4.33%
Operating Expenses to Revenue
27.03% 19.24% 16.36% 16.65% 19.78% 17.44% 13.30% 18.32% 16.23% 16.10% 18.21%
Earnings before Interest and Taxes (EBIT)
-18 25 0.29 7.63 13 7.48 29 13 5.74 1.32 -6.27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-13 30 5.18 13 18 12 34 18 10 5.52 -2.24
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.95 2.32 2.97 1.80 1.56 1.98 1.45 1.09 0.94 0.88 0.91
Price to Tangible Book Value (P/TBV)
2.99 2.36 3.02 1.83 1.59 2.02 1.48 1.11 0.96 0.93 0.96
Price to Revenue (P/Rev)
1.00 0.74 0.87 0.52 0.45 0.54 0.39 0.29 0.24 0.23 0.27
Price to Earnings (P/E)
440.21 20.41 67.42 12.39 7.55 9.53 10.24 32.15 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.23% 4.90% 1.48% 8.07% 13.24% 10.49% 9.76% 3.11% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
4.34 3.02 3.39 2.00 1.73 2.23 1.55 1.11 0.93 0.87 0.90
Enterprise Value to Revenue (EV/Rev)
0.86 0.63 0.82 0.47 0.39 0.48 0.34 0.24 0.21 0.21 0.23
Enterprise Value to EBITDA (EV/EBITDA)
20.17 7.85 13.76 4.96 3.84 5.39 4.19 5.88 9.01 38.14 28.24
Enterprise Value to EBIT (EV/EBIT)
47.45 11.17 23.09 6.63 4.98 7.17 5.69 12.93 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
102.69 11.91 23.85 6.83 4.11 5.32 6.37 16.70 75.11 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
8.17 6.32 10.47 6.02 4.02 4.90 4.92 12.20 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
23.15 10.11 51.93 12.42 5.89 7.48 10.21 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.16 0.25 0.32 0.23 0.21 0.25 0.19 0.09 0.13 0.15 0.13
Long-Term Debt to Equity
0.15 0.24 0.31 0.22 0.21 0.25 0.19 0.09 0.13 0.15 0.13
Financial Leverage
-0.33 -0.28 -0.18 -0.19 -0.18 -0.15 -0.15 -0.23 -0.22 -0.28 -0.33
Leverage Ratio
2.01 2.20 2.31 2.27 2.29 2.46 2.41 2.32 2.33 2.36 2.26
Compound Leverage Factor
1.96 2.22 1.75 2.13 2.17 2.03 2.33 2.28 2.17 1.89 2.28
Debt to Total Capital
13.51% 20.04% 24.18% 18.63% 17.46% 20.22% 16.26% 8.12% 11.65% 13.28% 11.44%
Short-Term Debt to Total Capital
0.48% 0.46% 0.48% 0.51% 0.52% 0.54% 0.57% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
13.03% 19.58% 23.70% 18.12% 16.93% 19.69% 15.69% 8.12% 11.65% 13.28% 11.44%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
86.49% 79.96% 75.82% 81.37% 82.54% 79.78% 83.74% 91.88% 88.35% 86.72% 88.56%
Debt to EBITDA
1.25 0.99 1.57 0.71 0.61 0.77 0.64 0.57 1.44 7.35 4.60
Net Debt to EBITDA
-3.33 -1.37 -0.87 -0.63 -0.66 -0.60 -0.59 -1.14 -1.26 -4.34 -4.21
Long-Term Debt to EBITDA
1.20 0.97 1.54 0.69 0.59 0.75 0.62 0.57 1.44 7.35 4.60
Debt to NOPAT
6.34 1.51 2.73 0.98 0.65 0.76 0.97 1.62 12.03 -3.78 -4.83
Net Debt to NOPAT
-16.95 -2.08 -1.50 -0.86 -0.71 -0.60 -0.90 -3.23 -10.54 2.23 4.42
Long-Term Debt to NOPAT
6.12 1.47 2.67 0.95 0.63 0.74 0.94 1.62 12.03 -3.78 -4.83
Altman Z-Score
4.22 3.81 3.65 3.33 3.43 3.39 3.23 2.85 2.56 2.29 2.23
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.43 2.35 2.17 2.09 2.21 2.03 1.89 1.63 1.61 1.52 1.53
Quick Ratio
1.41 1.37 1.16 1.03 1.04 0.95 0.85 0.65 0.60 0.54 0.56
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
20 21 -526 -18 -16 -15 11 1.37 -23 -65 -74
Operating Cash Flow to CapEx
292.15% 816.79% 386.83% 287.73% 218.04% 538.48% 425.89% 728.19% 230.92% 15.90% -221.72%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.56 1.54 1.53 1.64 1.70 1.70 1.66 1.66 1.63 1.50 1.47
Accounts Receivable Turnover
8.16 7.25 6.30 7.20 7.50 7.20 6.82 7.15 6.65 6.30 6.66
Inventory Turnover
4.68 4.62 4.29 4.14 3.89 3.93 4.09 4.25 4.18 4.20 4.37
Fixed Asset Turnover
10.95 11.21 11.14 11.37 11.11 11.26 11.28 10.86 10.70 10.14 9.92
Accounts Payable Turnover
12.58 10.94 9.26 9.29 9.87 8.66 8.53 8.38 8.65 7.22 7.53
Days Sales Outstanding (DSO)
44.75 50.34 57.93 50.68 48.64 50.72 53.49 51.08 54.90 57.94 54.82
Days Inventory Outstanding (DIO)
77.97 79.02 85.00 88.07 93.93 92.98 89.16 85.93 87.23 86.95 83.56
Days Payable Outstanding (DPO)
29.01 33.35 39.41 39.30 36.96 42.16 42.79 43.54 42.17 50.53 48.49
Cash Conversion Cycle (CCC)
93.71 96.01 103.51 99.45 105.61 101.54 99.86 93.46 99.96 94.35 89.89
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
159 171 196 191 182 179 181 165 159 157 165
Invested Capital Turnover
4.70 4.70 4.30 4.59 4.77 4.93 4.71 4.98 4.88 4.94 4.92
Increase / (Decrease) in Invested Capital
-23 -7.69 15 25 23 22 17 28 28 46 70
Enterprise Value (EV)
688 516 665 381 315 398 281 183 148 137 148
Market Capitalization
802 606 706 429 369 443 321 219 168 153 170
Book Value per Share
$5.80 $5.59 $5.15 $5.17 $5.12 $4.88 $4.84 $4.42 $3.94 $3.83 $4.15
Tangible Book Value per Share
$5.72 $5.51 $5.06 $5.08 $5.03 $4.79 $4.74 $4.32 $3.85 $3.63 $3.94
Total Capital
315 326 314 293 286 280 264 219 203 199 211
Total Debt
43 65 76 55 50 57 43 18 24 26 24
Total Long-Term Debt
41 64 74 53 48 55 41 18 24 26 24
Net Debt
-114 -90 -42 -48 -55 -45 -40 -35 -21 -16 -22
Capital Expenditures (CapEx)
4.11 5.31 5.04 3.29 4.35 4.65 4.52 3.37 5.39 5.52 10
Debt-free, Cash-free Net Working Capital (DFCFNWC)
101 110 135 129 130 124 129 107 118 111 106
Debt-free Net Working Capital (DFNWC)
233 244 232 211 207 198 184 132 129 119 118
Net Working Capital (NWC)
232 243 230 210 205 196 182 132 129 119 118
Net Nonoperating Expense (NNE)
15 -8.00 -506 4.31 -3.91 4.67 8.28 8.23 1.24 -5.80 1.46
Net Nonoperating Obligations (NNO)
-114 -90 -42 -48 -55 -45 -40 -35 -21 -16 -22
Total Depreciation and Amortization (D&A)
4.91 4.90 4.89 4.92 4.88 4.83 4.67 4.45 4.32 4.20 4.03
Debt-free, Cash-free Net Working Capital to Revenue
12.67% 13.39% 16.61% 15.83% 15.96% 15.04% 15.81% 14.22% 16.73% 16.78% 16.68%
Debt-free Net Working Capital to Revenue
29.19% 29.76% 28.58% 25.81% 25.46% 23.94% 22.55% 17.57% 18.32% 17.94% 18.57%
Net Working Capital to Revenue
29.00% 29.58% 28.40% 25.63% 25.28% 23.76% 22.37% 17.57% 18.32% 17.94% 18.57%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.36) $0.46 ($0.11) $0.05 $0.23 $0.05 $0.42 $0.48 $0.08 ($0.29) ($0.12)
Adjusted Weighted Average Basic Shares Outstanding
47.76M 46.80M 46.31M 45.90M 46.17M 46.03M 45.65M 45.40M 45.39M 45.32M 45.10M
Adjusted Diluted Earnings per Share
($0.36) $0.22 ($0.11) $0.18 $0.09 $0.05 $0.42 $0.48 $0.08 ($0.29) ($0.12)
Adjusted Weighted Average Diluted Shares Outstanding
47.76M 51.72M 46.31M 46.54M 50.84M 46.71M 46.20M 45.52M 45.45M 45.32M 45.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
49.89M 46.99M 46.65M 46.30M 46.19M 46.18M 45.72M 45.70M 45.47M 45.47M 45.03M
Normalized Net Operating Profit after Tax (NOPAT)
-2.54 13 16 14 6.83 14 27 13 4.95 1.07 -3.86
Normalized NOPAT Margin
-1.70% 6.43% 7.03% 6.30% 4.01% 6.82% 11.82% 6.09% 2.68% 0.57% -2.25%
Pre Tax Income Margin
-11.92% 12.09% 0.10% 3.32% 7.42% 3.09% 12.08% 6.28% 2.89% 0.56% -3.68%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
494.84% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Daktronics' Financials

When does Daktronics's fiscal year end?

According to the most recent income statement we have on file, Daktronics' financial year ends in April. Their financial year 2024 ended on April 27, 2024.

How has Daktronics' net income changed over the last 2 years?

Daktronics' net income appears to be on an upward trend, with a most recent value of $34.62 million in 2024, rising from $592 thousand in 2022. The previous period was $6.80 million in 2023. See Daktronics' forecast for analyst expectations on what’s next for the company.

What is Daktronics's operating income?
Daktronics's total operating income in 2024 was $87.12 million, based on the following breakdown:
  • Total Gross Profit: $222.44 million
  • Total Operating Expenses: $135.33 million
How has Daktronics revenue changed over the last 2 years?

Over the last 2 years, Daktronics' total revenue changed from $610.97 million in 2022 to $818.08 million in 2024, a change of 33.9%.

How much debt does Daktronics have?

Daktronics' total liabilities were at $289.09 million at the end of 2024, a 8.2% increase from 2023, and a 16.0% increase since 2022.

How much cash does Daktronics have?

In the past 2 years, Daktronics' cash and equivalents has ranged from $17.14 million in 2022 to $81.30 million in 2024, and is currently $81.30 million as of their latest financial filing in 2024.

How has Daktronics' book value per share changed over the last 2 years?

Over the last 2 years, Daktronics' book value per share changed from 4.21 in 2022 to 5.17 in 2024, a change of 22.7%.



This page (NASDAQ:DAKT) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners